• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?接受过敏疫苗接种患者的特征:社会经济因素在多大程度上发挥作用?
Eur J Public Health. 2011 Jun;21(3):323-8. doi: 10.1093/eurpub/ckq063. Epub 2010 May 19.
2
Clinical and patient based evaluation of immunotherapy for grass pollen and mite allergy.基于临床和患者的草花粉及螨过敏免疫疗法评估
Allergol Immunopathol (Madr). 2005 Sep-Oct;33(5):264-9. doi: 10.1157/13080929.
3
Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.采用特异性免疫疗法治疗的气传花粉过敏患者的口腔过敏综合征
Acta Dermatovenerol Croat. 2008;16(1):19-24.
4
Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.草花粉免疫疗法作为儿童季节性过敏性哮喘的一种有效治疗方法。
J Allergy Clin Immunol. 2006 Feb;117(2):263-8. doi: 10.1016/j.jaci.2005.09.054.
5
The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis.抗IgE治疗对季节性变应性鼻炎患儿体外白三烯释放的影响。
J Allergy Clin Immunol. 2002 Nov;110(5):728-35. doi: 10.1067/mai.2002.128804.
6
Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.对于患有季节性变应性鼻结膜炎合并季节性变应性哮喘的患者,奥马珠单抗与特异性免疫疗法联合使用优于单纯免疫疗法。
Clin Exp Allergy. 2009 Feb;39(2):271-9. doi: 10.1111/j.1365-2222.2008.03121.x. Epub 2008 Oct 30.
7
Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy.草花粉和螨过敏皮下特异性免疫疗法的卫生经济学分析
Allergol Immunopathol (Madr). 2005 Nov-Dec;33(6):296-302. doi: 10.1016/s0301-0546(05)73246-8.
8
[Preventive immunotherapy].[预防性免疫疗法]
Allergol Immunopathol (Madr). 2000 May-Jun;28(3):89-93.
9
Congruence between international guidelines and mite specific immunotherapy prescribing practices.国际指南与尘螨特异性免疫治疗处方实践的一致性。
Respir Med. 2011 Oct;105(10):1441-8. doi: 10.1016/j.rmed.2011.05.003. Epub 2011 May 31.
10
Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.同期舌下免疫疗法可降低变应性鼻结膜炎患儿患哮喘的风险。
J Allergy Clin Immunol. 2004 Oct;114(4):851-7. doi: 10.1016/j.jaci.2004.07.012.

引用本文的文献

1
The construct validity of the Child Health Utility 9D-DK instrument.儿童健康效用 9D-DK 量表的构建效度。
Health Qual Life Outcomes. 2019 Dec 23;17(1):187. doi: 10.1186/s12955-019-1256-0.
2
Adjustment of foreign EQ-5D-3L utilities can increase their transferability.调整国外EQ-5D-3L效用值可提高其转移性。
Clinicoecon Outcomes Res. 2015 Dec 15;7:629-36. doi: 10.2147/CEOR.S93280. eCollection 2015.
3
Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days.真实世界前瞻性随访研究中的患者相关结局:变应原免疫治疗提高生活质量和减少病假。
World Allergy Organ J. 2013 Sep 9;6(1):15. doi: 10.1186/1939-4551-6-15.

本文引用的文献

1
Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy.丹麦呼吸道过敏患者对过敏疫苗接种的支付意愿。
Int J Technol Assess Health Care. 2010 Jan;26(1):20-9. doi: 10.1017/S026646230999081X.
2
Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires.使用通用问卷和疾病特异性问卷评估变应性鼻结膜炎的生活质量。
Allergy. 2008 Mar;63(3):284-91. doi: 10.1111/j.1398-9995.2007.01583.x.
3
The use of grass pollen-specific immunotherapy among grass pollen allergic rhinitis in the general population.普通人群中草花粉特异性免疫疗法在草花粉过敏性鼻炎中的应用。
Allergy. 2007 Jul;62(7):825-6. doi: 10.1111/j.1398-9995.2007.01359.x.
4
Can asthma control be improved by understanding the patient's perspective?通过了解患者的观点能否改善哮喘控制?
BMC Pulm Med. 2007 May 22;7:8. doi: 10.1186/1471-2466-7-8.
5
GINA guidelines on asthma and beyond.《全球哮喘防治创议》关于哮喘及其他相关疾病的指南。
Allergy. 2007 Feb;62(2):102-12. doi: 10.1111/j.1398-9995.2006.01305.x.
6
Specific immunotherapy--an optimistic future.特异性免疫疗法——前景乐观。
Allergy. 2006 Oct;61(10):1155-8. doi: 10.1111/j.1398-9995.2006.01237.x.
7
Standards for practical allergen-specific immunotherapy.特异性变应原免疫治疗实践标准。
Allergy. 2006;61 Suppl 82:1-20. doi: 10.1111/j.1398-9995.2006.01219_1.x.
8
Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy.草花粉和螨过敏皮下特异性免疫疗法的卫生经济学分析
Allergol Immunopathol (Madr). 2005 Nov-Dec;33(6):296-302. doi: 10.1016/s0301-0546(05)73246-8.
9
Clinical and patient based evaluation of immunotherapy for grass pollen and mite allergy.基于临床和患者的草花粉及螨过敏免疫疗法评估
Allergol Immunopathol (Madr). 2005 Sep-Oct;33(5):264-9. doi: 10.1157/13080929.
10
Allergic disease in urban and rural populations: increasing prevalence with increasing urbanization.城乡人口中的过敏性疾病:随着城市化进程加剧,患病率不断上升。
Allergy. 2005 Nov;60(11):1357-60. doi: 10.1111/j.1398-9995.2005.00961.x.

接受过敏疫苗接种患者的特征:社会经济因素在多大程度上发挥作用?

Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?

机构信息

Institute of Public Health-Health Economics, University of Southern Denmark, Odense C, Denmark.

出版信息

Eur J Public Health. 2011 Jun;21(3):323-8. doi: 10.1093/eurpub/ckq063. Epub 2010 May 19.

DOI:10.1093/eurpub/ckq063
PMID:20484343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3098894/
Abstract

BACKGROUND

Little is known about characteristics of patients receiving allergen-specific immunotherapy. Identifying obstacles to appropriate treatment according to guidelines may facilitate the development of strategies aiming at improved treatment of patients with allergic respiratory diseases. The objective of this study was to investigate differences in disease severity, demographic and socioeconomic status between allergic rhinitis patients receiving allergen-specific immunotherapy and allergic rhinitis patients not receiving allergen-specific immunotherapy.

METHODS

A total of 366 patients were studied of whom 210 were going to receive subcutaneously administrated immunotherapy (SIT) against grass pollen and/or house dust mite allergy. The severity of rhino-conjunctivitis (hay fever) and/or asthma was classified according to international guidelines. The questionnaires included an EQ-5D visual analogue scale instrument and some socio-economic questions.

RESULTS

Severity of disease, young age, high level of education as well as greater perceived impairment of health-related quality of life due to allergic symptoms were significantly associated with use of SIT. Somewhat unexpectedly, household income was not associated with use of SIT.

CONCLUSION

Use of SIT was associated with both disease severity measures and educational level, but not income level. These results suggest social inequality as reflected by lower use of SIT among patients with lower educational level may represent an obstacle to treatment with SIT.

摘要

背景

目前对于接受变应原特异性免疫治疗患者的特征知之甚少。根据指南确定适当治疗的障碍,可能有助于制定旨在改善变应性呼吸道疾病患者治疗的策略。本研究的目的是调查接受变应原特异性免疫治疗和未接受变应原特异性免疫治疗的变应性鼻炎患者在疾病严重程度、人口统计学和社会经济状况方面的差异。

方法

共研究了 366 名患者,其中 210 名患者将接受皮下免疫治疗(SIT)治疗草花粉和/或屋尘螨过敏。鼻结膜炎(花粉症)和/或哮喘的严重程度根据国际指南进行分类。调查问卷包括 EQ-5D 视觉模拟量表和一些社会经济问题。

结果

疾病严重程度、年龄较小、教育程度较高以及因过敏症状对健康相关生活质量的感知损害较大,与 SIT 的使用显著相关。有点出人意料的是,家庭收入与 SIT 的使用无关。

结论

SIT 的使用与疾病严重程度和教育程度有关,但与收入水平无关。这些结果表明,社会不平等反映在教育程度较低的患者中 SIT 的使用较低,这可能是 SIT 治疗的障碍。